Biotium Announces Optimized Antibody Labeling Kits for STORM Super-Resolution Microscopy
February 16, 2022
New Mix-n-Stain™ Antibody Labeling Kits offer an optimal low degree of labeling with your choice of Biotium’s superior CF® Dyes for STORM Fremont, CA -- Life Science Newswire – Biotium, a supplier of cutting-edge life science reagents, is expanding their line of industry-leading Mix-n-Stain™ labeling kits with new kits designed specifically for producing antibody conjugates [...]
Avantor® Announces Planned Retirement of Rajiv Gupta, Board Chairman
February 16, 2022
Gupta to retire at the end of his current term on May 12, 2022, after more than a decade of service, during which time Avantor has transformed into a global life sciences leader RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, [...]
February 16, 2022
Winnipeg, MB – Case Western Reserve University (CWRU) has selected Cubresa’s Preclinical NuPET™ Insert System to add to their suite of imaging tools. The NuPET 66 will support research in a wide range of application areas including cancer, neurodegenerative diseases, diabetes, and genetic diseases such as cystic fibrosis, leukodystrophies, and polycystic kidney disease. “The NuPET [...]
February 16, 2022
INDIANAPOLIS – Beckman Coulter Life Sciences continues to work with chemistry companies seeking collaborations to develop applications for the Biomek NGeniuS Next Generation Library Preparation System ahead of its launch. An application development agreement has been signed with Illumina, a developer of solutions for the sequencing and analysis of genomes, to develop new applications on [...]
Fortis Life Sciences Highlights First Year Success
February 16, 2022
Company expands into key market verticals in diagnostics, therapeutics, and research discovery with solutions for proteins, genomics, and diagnostic assay development services. Waltham, MA – Fortis Life Sciences, a strategic platform company providing capital, expertise, and operational resources to grow founder-led life science companies, today announced highlights from its first year of operations. Fortis delivered [...]
Trace Matters Introduces SUPER Mass Spec and SPion Link
February 15, 2022
SOMERVILLE, Mass. -- Trace Matters Scientific today introduced two new technologies, SUPER Mass Spec™ and SPion Link™, both category-defining mass spectrometry technologies enabling a quantum leap in the scientific study of complex clinical samples, such as tissue and blood samples. These technologies will empower scientists by providing exceptional mass spectrometry capabilities, which were highly desired [...]
February 15, 2022
Company to commercialize and create single-cell multi-omics products Seattle, WA -- Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall Wace and Janus Henderson Investors. Soleus Capital, Logos Capital and Bioeconomy Capital also participated in the round, bringing Parse Biosciences’ total funding to [...]
February 15, 2022
WALTHAM, Mass. -- Cell and gene therapy innovators can now leverage new integrated commercial packaging and distribution services from Thermo Fisher Scientific, designed to seamlessly transition therapies from clinic to commercial launch for patients across the U.S. and Europe. The Patheon Commercial Packaging Services for Cell and Gene Therapies (CGT) is an end-to-end solution combining the GMP [...]
Takara Bio USA Wins EU Opposition Hearing on its Foundational NGS Library Enrichment Patent
February 15, 2022
SAN JOSE, Calif. -- Takara Bio USA, Inc. (TBUSA) today announced that the European Patent Office has reviewed and confirmed the validity of TBUSA’s granted European patent EP 3105325, entitled "Methods of depleting a target molecule from an initial collection of nucleic acids, and compositions and kits for practicing the same." TBUSA’s patent was opposed [...]
Element Strengthens Leadership Team to Advance Novel Applications Development and Scientific Affairs
February 15, 2022
Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the appointment of Shawn Levy, Ph.D., as Senior Vice President of Applications and Scientific Affairs. A world-renowned pioneer in genomics research, Dr. Levy brings more than 20 years of in-depth knowledge to support Element's growth and strategic plans for its first sequencing platform, AVITI™, [...]

